Trials / Completed
CompletedNCT01464333
Special Investigation (Long-term Investigation) in Patients With Crohn's Disease
Humira® for Subcutaneous Injection Protocol for Special Investigation (Long-term Treatment for Crohn's Disease Patients)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 511 (actual)
- Sponsor
- AbbVie (prior sponsor, Abbott) · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study of Humira will be conducted to obtain information on the safety (especially profile of malignant tumors and serious infections) and effectiveness in patients with Crohn's disease who are receiving Humira for a long period of time.
Conditions
Timeline
- Start date
- 2011-12-16
- Primary completion
- 2018-03-31
- Completion
- 2018-03-31
- First posted
- 2011-11-03
- Last updated
- 2019-05-20
- Results posted
- 2019-05-20
Source: ClinicalTrials.gov record NCT01464333. Inclusion in this directory is not an endorsement.